OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Update on Allergy test menu
Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it has CE-Marked its first allergy screening assay to be run on the IDS-iSYS automated instrument.
The assay uses a mix of five different single allergens and is the first mix in a planned programme to develop a range of mixes to meet market needs. Screening assays, which contain multiple allergens, are a useful tool in helping to efficiently diagnose the causes of patient allergies.
Colin King, CEO of the Company, said: "The Grass mix is the first of five mixes required to enhance our Allergy panel and further demonstrates our excellent development capability. We will continue to focus our efforts to bring the remaining assays to the market, which will allow us to be more commercially competitive."
Contacts:
Omega Diagnostics Group PLC |
Tel: 01259 763 030 |
Bill Rhodes, Interim Non-Executive Chairman Colin King, Chief Executive |
|
Kieron Harbinson, Group Finance Director |
|
|
|
finnCap Ltd |
Tel: 020 7220 0500 |
Geoff Nash/Hannah Boros (Corporate Finance) |
|
Camille Gochez (ECM) |
|
|
|
Walbrook PR Limited |
Tel: 020 7933 8780 or omega@walbrookpr.com |
Paul McManus |
Mob: 07980 541 893 |
Lianne Cawthorne |
Mob: 07584 391 303 |